# Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy

> **NCT02527213** · PHASE3 · WITHDRAWN · sponsor: **American Regent, Inc.**

## Conditions studied

- Calciphylaxis
- Calcific Uremic Arteriolopathy

## Interventions

- **DRUG:** Sodium thiosulfate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02527213
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-01-30
- **Primary completion:** 2016-08-29
- **Final completion:** 2016-08-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company decision -terminated on 30 October 2015
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02527213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02527213, "Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02527213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*